Clinical Trials Browser

Phase 1 × defactinib × Thoracic × Clear all

NCT04201145 2020-11-17

Pembrolizumab + Defactinib In Pleural Mesothelioma

Phase 1 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02372227 2017-01-30

A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma

Phase 1 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant